
Thai N. Pham
Examiner (ID: 11011, Phone: (571)270-5518 , Office: P/2844 )
| Most Active Art Unit | 2844 |
| Art Unit(s) | 2844, 2821, 4134 |
| Total Applications | 1345 |
| Issued Applications | 1066 |
| Pending Applications | 85 |
| Abandoned Applications | 219 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9561998
[patent_doc_number] => 20140179711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'PROCESS FOR PREPARING 2-AMINOTHIAZOLE-5-AROMATIC CARBOXAMIDES AS KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/191620
[patent_app_country] => US
[patent_app_date] => 2014-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19266
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14191620
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/191620 | PROCESS FOR PREPARING 2-AMINOTHIAZOLE-5-AROMATIC CARBOXAMIDES AS KINASE INHIBITORS | Feb 26, 2014 | Abandoned |
Array
(
[id] => 11676566
[patent_doc_number] => 09675070
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-13
[patent_title] => 'Halogen-substituted compounds'
[patent_app_type] => utility
[patent_app_number] => 14/767621
[patent_app_country] => US
[patent_app_date] => 2014-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46161
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14767621
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/767621 | Halogen-substituted compounds | Feb 26, 2014 | Issued |
Array
(
[id] => 9739846
[patent_doc_number] => 20140275565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'PROCESS FOR THE PREPARATION OF CERTAIN TRIARYL RHAMNOSE CARBAMATES'
[patent_app_type] => utility
[patent_app_number] => 14/192459
[patent_app_country] => US
[patent_app_date] => 2014-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8189
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14192459
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/192459 | PROCESS FOR THE PREPARATION OF CERTAIN TRIARYL RHAMNOSE CARBAMATES | Feb 26, 2014 | Abandoned |
Array
(
[id] => 11054348
[patent_doc_number] => 20160251311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-01
[patent_title] => 'PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY ENRICHED 3-AMINOPIPERIDINE'
[patent_app_type] => utility
[patent_app_number] => 14/768751
[patent_app_country] => US
[patent_app_date] => 2014-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16545
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14768751
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/768751 | Process for the preparation of enantiomerically enriched 3-aminopiperidine | Feb 18, 2014 | Issued |
Array
(
[id] => 10476043
[patent_doc_number] => 20150361060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-17
[patent_title] => 'CENTRALLY ACTIVE AND ORALLY BIOAVAILABLE ANTIDOTES FOR ORGANOPHOSPHATE EXPOSURE AND METHODS FOR MAKING AND USING THEM'
[patent_app_type] => utility
[patent_app_number] => 14/766272
[patent_app_country] => US
[patent_app_date] => 2014-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 23463
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14766272
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/766272 | CENTRALLY ACTIVE AND ORALLY BIOAVAILABLE ANTIDOTES FOR ORGANOPHOSPHATE EXPOSURE AND METHODS FOR MAKING AND USING THEM | Feb 14, 2014 | Abandoned |
Array
(
[id] => 9699507
[patent_doc_number] => 20140249192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-04
[patent_title] => 'COMPOUNDS ACT AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE'
[patent_app_type] => utility
[patent_app_number] => 14/178982
[patent_app_country] => US
[patent_app_date] => 2014-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11956
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14178982
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/178982 | Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response | Feb 11, 2014 | Issued |
Array
(
[id] => 10483235
[patent_doc_number] => 20150368254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/764426
[patent_app_country] => US
[patent_app_date] => 2014-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 65789
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 38
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14764426
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/764426 | Spiro-lactam NMDA receptor modulators and uses thereof | Jan 28, 2014 | Issued |
Array
(
[id] => 13139657
[patent_doc_number] => 10087149
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-02
[patent_title] => Selective histone deacetylase 8 inhibitors
[patent_app_type] => utility
[patent_app_number] => 14/763013
[patent_app_country] => US
[patent_app_date] => 2014-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 26343
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 377
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14763013
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/763013 | Selective histone deacetylase 8 inhibitors | Jan 23, 2014 | Issued |
Array
(
[id] => 9685263
[patent_doc_number] => 20140242028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'ANTIVIRAL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/159566
[patent_app_country] => US
[patent_app_date] => 2014-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27236
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14159566
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/159566 | ANTIVIRAL COMPOUNDS | Jan 20, 2014 | Abandoned |
Array
(
[id] => 9464010
[patent_doc_number] => 20140128437
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-08
[patent_title] => 'HETEROCYCLIC INHIBITORS OF NECROPTOSIS'
[patent_app_type] => utility
[patent_app_number] => 14/152703
[patent_app_country] => US
[patent_app_date] => 2014-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10059
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14152703
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/152703 | Heterocyclic inhibitors of necroptosis | Jan 9, 2014 | Issued |
Array
(
[id] => 10961620
[patent_doc_number] => 20140364641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-11
[patent_title] => 'Tetrasubstituted Benzenes'
[patent_app_type] => utility
[patent_app_number] => 14/151232
[patent_app_country] => US
[patent_app_date] => 2014-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 119680
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14151232
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/151232 | Tetrasubstituted Benzenes | Jan 8, 2014 | Abandoned |
Array
(
[id] => 10055802
[patent_doc_number] => 09095138
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-04
[patent_title] => 'Isoxazoline insecticides'
[patent_app_type] => utility
[patent_app_number] => 14/148410
[patent_app_country] => US
[patent_app_date] => 2014-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56421
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14148410
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/148410 | Isoxazoline insecticides | Jan 5, 2014 | Issued |
Array
(
[id] => 10055802
[patent_doc_number] => 09095138
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-04
[patent_title] => 'Isoxazoline insecticides'
[patent_app_type] => utility
[patent_app_number] => 14/148410
[patent_app_country] => US
[patent_app_date] => 2014-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56421
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14148410
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/148410 | Isoxazoline insecticides | Jan 5, 2014 | Issued |
Array
(
[id] => 11521582
[patent_doc_number] => 09604968
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-28
[patent_title] => 'Pure crystalline Form II of L-malic acid salt of sunitinib and processes for its preparation'
[patent_app_type] => utility
[patent_app_number] => 14/147757
[patent_app_country] => US
[patent_app_date] => 2014-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3220
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14147757
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/147757 | Pure crystalline Form II of L-malic acid salt of sunitinib and processes for its preparation | Jan 5, 2014 | Issued |
Array
(
[id] => 9448978
[patent_doc_number] => 20140120147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'ISOXAZOLINE DERIVATIVES AS PESTICIDES'
[patent_app_type] => utility
[patent_app_number] => 14/148205
[patent_app_country] => US
[patent_app_date] => 2014-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17226
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14148205
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/148205 | Isoxazoline derivatives as pesticides | Jan 5, 2014 | Issued |
Array
(
[id] => 9477941
[patent_doc_number] => 20140135400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'NOVEL ANTAGONISTS OF THE GLUCAGON RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 14/147457
[patent_app_country] => US
[patent_app_date] => 2014-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 122027
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14147457
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/147457 | Antagonists of the glucagon receptor | Jan 2, 2014 | Issued |
Array
(
[id] => 10468492
[patent_doc_number] => 20150353509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'A Compound 1,4,5-Trisubstituted1,2,3-Triazole, Process To Obtain And Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/655676
[patent_app_country] => US
[patent_app_date] => 2013-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7488
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14655676
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/655676 | A Compound 1,4,5-Trisubstituted1,2,3-Triazole, Process To Obtain And Uses Thereof | Dec 25, 2013 | Abandoned |
Array
(
[id] => 10451894
[patent_doc_number] => 20150336908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-26
[patent_title] => 'TETRAZOLINONE COMPOUND AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/654575
[patent_app_country] => US
[patent_app_date] => 2013-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 113344
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14654575
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/654575 | Tetrazolinone compound and use thereof | Dec 23, 2013 | Issued |
Array
(
[id] => 10940044
[patent_doc_number] => 20140343066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => '5-SUBSTITUTED INDAZOLES AS KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 14/136359
[patent_app_country] => US
[patent_app_date] => 2013-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 99138
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14136359
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/136359 | 5-substituted indazoles as kinase inhibitors | Dec 19, 2013 | Issued |
Array
(
[id] => 10466386
[patent_doc_number] => 20150351401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'SUBSTITUTED [1,2,4]TRIAZOLE AND IMIDAZOLE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/653581
[patent_app_country] => US
[patent_app_date] => 2013-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92019
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14653581
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/653581 | SUBSTITUTED [1,2,4]TRIAZOLE AND IMIDAZOLE COMPOUNDS | Dec 12, 2013 | Abandoned |